Calimlim, Brian
AbbVie (United States)
2 papers on CoChatORCID 0000-0002-6463-6433
Most cited papers
- Verified
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials
Guttman-Yassky, E., Teixeira, H. D., Simpson, E. L., Papp, K. A., Pangan, A. L., Blauvelt, A., Thaçi, D., Chu, C.-Y., Hong, H. C.-H., Katoh, N., et al. (2021) · The Lancet
Dermatology and Skin DiseasesAsthma and respiratory diseases
Cited by 583
- Verified
Switch Rates During Acute Treatment for Bipolar II Depression With Lithium, Sertraline, or the Two Combined: A Randomized Double-Blind Comparison
Altshuler, L. L., Sugar, C. A., McElroy, S. L., Calimlim, B., Gitlin, M., Keck, P. E., Aquino-Elias, A., Martens, B. E., Fischer, E. G., English, T. L., et al. (2017) · American Journal of Psychiatry
Bipolar Disorder and TreatmentTreatment of Major Depression
Cited by 68
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free